Summary: “MDMA was a therapy drug before it became a party drug,” says MAPS Founder and Executive Director Rick Doblin, Ph.D., in an interview with NBC News Now, “and we’re trying to bring it back to being a therapy drug.”
Watch this coverage for an overview of the staggering results from MAPS’ first Phase 3 trial of MDMA-assisted therapy for PTSD, as well as an explanation of MDMA itself, from its potential benefits to its possible physical and psychological side effects.
Originally appearing here.
Post-traumatic stress disorder is a condition that is nearly untreatable, but doctors are now studying whether MDMA, popularly known as ecstasy, can have a positive effect on the condition when paired with traditional talk therapy. Dr. Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies joins News NOW to discuss what the study found and how the illegal drug could be used to treat PTSD.